Research Topics
Genomes and GenesSpecies | M RembergerSummaryAffiliation: Karolinska Institutet Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantationMats Remberger
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden
Transpl Immunol 27:59-62. 2012..Low serum-levels of r-ATG early after transplantation seem to be a strong predictor for acute GVHD grades III-IV, TRM and a low incidence of relapse in patients treated with thymoglobulin before unrelated donor UCBT...
Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failureMats Remberger
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Clin Transplant 25:E68-76. 2011..005). We concluded that re-transplantation using RIC is a valid option for GF, especially in patients with non-malignant disorders...
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre studyM Remberger
Department of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 41:399-405. 2008..1%, while it was 38.0 and 85.0% in patients with one (n=29) or two (n=10) risk factors (P<0.001). We concluded that risk factors for acute GVHD using RIC are similar as using myeloablative conditioning...
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemiaMats Remberger
Centre for Allogeneic Stem Cell Transplantation and Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Eur J Haematol 80:419-28. 2008..Reasons for this may be improved tissue-typing techniques and supportive care and optimisation of the ATG dose...
C-reactive protein levels before reduced-intensity conditioning predict outcome after allogeneic stem cell transplantationMats Remberger
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Int J Hematol 92:161-7. 2010..It should be analyzed before conditioning, especially in patients with coexisting infection since patients with increased CRP and infection seem to have a very poor outcome after ASCT...
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantationMats Remberger
Department of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 13:675-82. 2007..In patients with and without major ABO mismatch the incidence of GF was 7.5% and 0.6% (P = .02), respectively. Using an ABO major mismatched graft increases the risk for GF after unrelated donor hematopoietic stem cell transplantation...
Improved survival after allogeneic hematopoietic stem cell transplantation in recent years. A single-center studyMats Remberger
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 17:1688-97. 2011..The problem of relapse still has to be remedied. Thus, several different developments together have resulted in significantly lower TRM and improved survival after HSCT over the last few years...
Anti-HLA antibodies in double umbilical cord blood transplantationClaudio G Brunstein
Blood and Marrow Transplantation Program, University of Minnesota, 420 Delaware Street, Minneapolis, MN 55455, USA
Biol Blood Marrow Transplant 17:1704-8. 2011..Further studies are needed to fully understand the value of anti-HLA antibody testing in dUCB graft selection and its impact on transplantation outcomes...
Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective studyMats Remberger
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, Sweden
Biol Blood Marrow Transplant 15:996-9. 2009..023. Low serum levels of r-IgG seem to be a strong predictor for aGVHD grades II-IV in patients treated with Thymoglobulin before unrelated donor HSCT...
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescentsMats Remberger
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, SE 141 86 Stockholm, Sweden
Transplantation 84:551-4. 2007..1). We found no differences in transplant-related mortality and survival in children and adolescents receiving BM or PBSC from unrelated donors. More rapid engraftment and a trend for less relapses in patients given PBSC grafts was noted...
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantationM Remberger
Centre for Allogeneic Stem Cell Transplantation, and Department of Clinical Immunology, Karolinska Institute, Huddinge Hospital, Sweden
Eur J Haematol 66:50-6. 2001..The cumulative probabilities of relapse were 37% in the both groups. This suggests that the Scandinavian population is more homogeneous with regard to minor histocompatibility antigens important for chronic, but not acute GVHD...
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantationO Ringden
Center for Allogeneic Stem Cell Transplantation, Department of Clinical Immunology, Huddinge Hospital, Huddinge, Sweden
Blood 94:455-64. 1999..01). One-year transplant-related mortality was 21% and 27% and survival was 53% and 54% in the BM and PBSC groups, respectively (NS). The 2-year relapse-free survival was 41% and 46% in the two groups, respectively...
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow TransplantaO Ringden
Centre for Allogeneic Stem Cell Transplantation, and the Department of Hematology, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
Blood 93:2196-201. 1999..01). In patients with chronic myeloid leukemia (CML) in first chronic phase, 7-year LFS was 72% and 83% in the two groups, respectively...
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre studyD Hauzenberger
Department of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Tissue Antigens 72:549-58. 2008..An HLA-C or -DQ mismatch had no significant impact on survival, TRM and relapse. In conclusion, compared with MUD, HLA class I allele mmUD had an increased risk of acute GVHD and TRM...
BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched graftsG Giraud
Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 41:737-42. 2008..6; P=0.03). However, when analysing HSCT performed with URD or RD grafts separately, BKV (OR 8.5; 95% CI 1.8-19.3; P=0.004) and MC (OR 5.9; 95% CI 1.3-11.3; P=0.009) increased the risk for HC only with a URD, but not with an RD graft...
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cellsK Le Blanc
Hematology Center, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Leukemia 21:1733-8. 2007..Thus, co-transplantation of MSC resulted in fast engraftment of absolute neutrophil count (ANC) and platelets and 100% donor chimerism, even in three patients regrafted for graft failure/rejection...
Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-upJ Aschan
Centre for Allogeneic Stem Cell Transplantation, Department of Hematology, Huddinge Hospital, Stockholm, Sweden
Clin Transplant 13:512-9. 1999..However, in patients with early leukemia conditioning with BU + CY, our method of individualizing the GVHD prophylaxis might be of value, since this group had the best RFS in this study...
Long-term salivary function after conditioning with busulfan, fractionated or single-dose TBIK Garming-Legert
Division of Oral and Maxillofacial Surgery, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden
Oral Dis 17:670-6. 2011..Does conditioning with fractionated total body irradiation (fTBI) or busulfan (Bu) causes less salivary dysfunction compared with single dose (sTBI) after hematopoietic stem cell transplantation (HSCT)...
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancerO Ringden
Department of Clinical Immunology, Karolinska Institutet, Huddinge Hospital, Sweden
Transplantation 69:2043-8. 2000..We investigated whether it were possible to induce mixed chimerism and obtain an antitumor effect in a patient with a large primary liver cancer after combined liver and bone marrow transplantation (BMT)...
Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantationM Remberger
Center for Allogeneic Stem Cell Transplantation, Department of Clinical Immunology, F79 Karolinska Institutet, Huddinge University Hospital, Huddinge, SE 141 86 Stockholm, Sweden
Pediatr Transplant 5:285-92. 2001..01). Hence, the use of polyclonal ATG as part of conditioning prior to ASCT in children is safe and the survival rate encouraging...
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantationH Hagglund
Departments of Transplantation Surgery, Clinical Immunology, Paediatrics, and Medicine, Karolinska Institute, Huddinge Hospital, Huddinge, Sweden
Blood 92:4568-72. 1998..02), and conditioning with busulphan (P =.02). Our conclusion is that norethisterone treatment should not be used in patients undergoing BMT and heparin prophylaxis did not affect the incidence or mortality of VOD...
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donorO Ringden
Centre for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 42:643-8. 2008..006). Although the material is small and heterogeneous, engraftment was delayed, leukocyte chimerism was not significantly different and survival was superior using UCB rather than MM URD transplants...
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survivalA C Norlin
Department of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 41:267-73. 2008..04) and an increased incidence of transplant-related mortality (27 vs 9%, P<0.01). IgG levels generally increase after SCT. Persistent low levels of IgG are a risk factor for death after SCT...
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reactionH Omar
Department of Medicine, Huddinge, Division of Haematology, Karolinska Institutet, Stockholm, Sweden
Transpl Infect Dis 11:393-9. 2009..The likelihood of PTLD is increased in the presence of specific risk factors. Monitoring of EBV DNA load and early administration of rituximab in patients with high EBV loads is recommended for high-risk patients...
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejectionJ Mattsson
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 45:235-8. 2010..In conclusion, the pretransplant cytotoxic T- and/or B-crossmatch is a poor predictor of rejection after allo-SCT...
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IVM Remberger
Centre for Allogeneic Stem Cell Transplantation, F79 Huddinge University Hospital, SE-141 86 Stockholm, Sweden
Bone Marrow Transplant 32:217-23. 2003..In conclusion, G-CSF given after HLA-identical sibling HSCT was associated with a higher risk of grades II-IV acute GVHD, but not transplant-related mortality...
Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantationB M Svahn
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet and Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 47:706-15. 2012..To conclude, major complications increased the costs of HSCT. Unrelated donor transplants were more expensive than HLA-identical sibling transplants. Costs were reduced in patients treated with NMC...
No impact of NOD2/CARD15 on outcome after SCTD Sairafi
Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 41:961-4. 2008..On the basis of these findings we conclude that a consideration to NOD2/CARD15 mutation status is not pertinent when selecting a donor for Allo-SCT at our centre...
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patientsP Ljungman
Department of Haematology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Br J Haematol 111:774-81. 2000..04) influenced HHV-6 DNA levels. HHV-6 viral load was significantly correlated with delayed platelet engraftment in both univariate (P < 0.01) and multivariate analysis, and to the number of platelet transfusions...
Fractionated TBI correlates with less T cell mixed chimerism but increased risk of relapse compared to busulphan in patients with haematological malignancies after allogeneic stem cell transplantationJ Mattsson
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 32:477-83. 2003..01). In multivariate analysis adjusted for diagnosis, busulphan-treated patients showed both a better survival (P=0.04) and less probability of relapse (0.03) compared to TBI-treated patients...
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulinM Remberger
Department of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Clin Transplant 15:147-53. 2001..Most patients died of GVHD, with virus or fungal infections as contributing causes of death. To conclude, treatment of severe acute GVHD is difficult and ATG, in our hands, adds nothing to conventional pharmacological treatment...
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirusKajsa Larsson
Division for Hematology, Department of Medicine, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Transplantation 77:526-31. 2004..The aim of this study was to investigate the relationship between cytomegalovirus (CMV) and extensive chronic graft-versus-host disease (GvHD) after allogeneic stem-cell transplantation (SCT)...
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplantsRichard Olsson
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institute, Karolinska University Hospital, Huddinge, Sweden
Eur J Haematol 84:323-31. 2010....
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital careBritt Marie Svahn
Centre for Allogeneic Stem Cell Transplantation, Department of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Blood 100:4317-24. 2002..03). To conclude, home care after SCT is a novel and safe approach. This study found it to be advantageous, compared with hospital care...
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?Olle Ringden
Centre for Allogeneic Stem Cell Transplantation, Division of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 10:128-34. 2004..The 5-year survival was 72%, 48%, and 30% with 0, 1, and 2 risk factors, respectively. We concluded that unrelated hematopoietic stem cell transplantation may be improved if an optimal donor and immunosuppression are chosen...
Disturbances in dental development and craniofacial growth in children treated with hematopoietic stem cell transplantationM Vesterbacka
Division of Orthodontics and Pediatric Dentistry, Department of Dental Medicine, Karolinska Institutet, Stockholm, Sweden
Orthod Craniofac Res 15:21-9. 2012..To investigate the correlation between age, degree of disturbances in dental development, and vertical growth of the face in children treated with hematopoietic stem cell transplantation (HSCT)...
T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantationP Hentschke
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden
Scand J Immunol 61:285-94. 2005..GVHD, infections and age are more important for immune reconstitution than type of conditioning...
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseasesO Ringden
Division of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 39:383-8. 2007..03). Treatment-related mortality was 4 and 15%, and 5-year survival was 89 and 85% in the FBC and MC groups. Although survival was similar, FBC is a promising alternative to MC in non-malignant disorders...
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantationL Barkholt
Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Bone Marrow Transplant 40:683-9. 2007..Interindividual variations in CsA uptake and metabolism may explain the wide variation of C2 levels without prediction for increased risk for severe aGVHD or infectious complication when C0 guided the CsA dosing...
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donorsM Remberger
Centre for Allogeneic Stem Cell Transplantation and Department of Clinical Immunology, Huddinge University Hospital, Stockholm, Sweden
Blood 98:1739-45. 2001..PBSC from HLA-compatible unrelated donors can be used safely as an alternative to BM for stem cell transplantation...
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantationL Barkholt
Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
Bone Marrow Transplant 41:785-90. 2008..There were two patients in the NAC group who developed VOD, as compared to three of the controls. To conclude, NAC does not improve liver toxicity after ASCT...
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationMats Remberger
Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 8:674-82. 2002..Patients with previous acute GVHD grades II to IV may benefit from more aggressive initial treatment. This possibility would have to be examined in clinical trials...
Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survivalA Gustafsson Jernberg
Department of Paediatrics, Karolinska Institutet, Huddinge University Hospital, Huddinge, Sweden
Bone Marrow Transplant 31:175-81. 2003..Acute GVHD was not an independent predictor for relapse or death in this study. This study is in support of a GVL effect in childhood leukaemia related to chronic GVHD, reducing the risk of relapse and improving survival...
Risk factors for fatal infectious complications developing late after allogeneic stem cell transplantationA Bjorklund
Hematology Center, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 40:1055-62. 2007..In conclusion, infections occurring later than 6 months after HSCT are important contributors to late non-relapse mortality after HSCT. CMV infection or acute GVHD markedly increase the risk...
Randomized PCR-based therapy and risk factors for invasive fungal infection following reduced-intensity conditioning and hematopoietic SCTO Blennow
Division of Infectious Diseases, Department of Medicine, Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 45:1710-8. 2010..In this study, PCR on peripheral blood was a poor indicator of IFI early after RIC HSCT. Aspergillus PCR tests performed on clinical suspicion after day 100 were insufficiently sensitive to be diagnostically useful...
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factorsPatrik Hentschke
Centre for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, Stockholm, Sweden. Patrik.Hentschke@ transpl.hs.sll.se
Transplantation 73:930-6. 2002..CONCLUSION: In multivariate analysis, high donor age, immunized female donor to male recipient, and grades II-IV acute GVHD were significantly associated with a longer time to clinical tolerance...
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donorsMats Remberger
Centre for Allogeneic Stem Cell Transplantation and Department of Clinical Immunology, Karolinska University Hospital, Stockholm, Sweden
Blood 105:548-51. 2005..In conclusion, PBSCs from HLA-compatible unrelated donors results in similar outcome compared to BM but implies an increased risk for extensive chronic GVHD...
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantationAndreas T Björklund
Center for Infectious Medicine, Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden
Blood 115:2686-94. 2010..Our results provide evidence against the emergence of alloreactive NK cells in HLA-identical allogeneic SCT...
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myelomaO Ringden
Department of Clinical Immunology, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 47:831-7. 2012..52, P=0.001). The reduction in relapse risk associated with cGVHD is consistent with a beneficial graft-vs-myeloma effect, but this did not translate into a survival advantage...
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donorsM Remberger
Center for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 29:391-7. 2002..27-0.97, P value = 0.03). No significant difference in the risk of relapse was seen (P = 0.63). This suggests that Thymoglobulin during conditioning may reduce non-relapse mortality after unrelated donor marrow transplantation...
The clinical importance of bronchoalveolar lavage in allogeneic SCT patients with pneumoniaU Forslöw
Department of Medicine, Division of Respiratory Medicine and Allergology, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 45:945-50. 2010..BAL resulted in a changed treatment in 32/68 (47%) episodes of pneumonia. To conclude, BAL is a safe and useful diagnostic procedure that should be performed early after the onset of pneumonia following allogeneic HSCT...
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantationB M Svahn
Center for Allogeneic Stem Cell Transplantation and the Division of Clinical Immunology, Karolinska Institute, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 36:511-6. 2005..04). Home care after ASCT is a novel approach that resulted in less TRM, similar incidence of chronic GVHD and relapse, and improved long-term survival compared to controls treated in the hospital...
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapseS Carlens
Centre for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, Sweden
Biol Blood Marrow Transplant 7:31-8. 2001..022). This study emphasizes the importance of early disease stage and presence of chronic GVHD for effective DLI...
A low body mass index is correlated with poor survival after allogeneic stem cell transplantationKatarina Le Blanc
Center for Allogeneic Stem Cell Transplantation, Division of Clinical Immunology, F79, Karolinska Institutet, Huddinge University Hospital, SE 141 86, Stockholm, Sweden
Haematologica 88:1044-52. 2003..The purpose of this study was to determine whether body mass index (BMI, kg body weight/height (in m2) is related to survival in recipients of allogeneic stem cell transplantation (ASCT)...
Risk factors in pediatric stem cell transplantation for leukemiaAsa Gustafsson Jernberg
Department of Pediatrics, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Pediatr Transplant 8:464-74. 2004..39) and death (RR 0.42). We conclude that in children with leukemia other specific donor characteristics such as HLA-matching, gender, parity, and exposure to herpes viruses were more important for outcome than relationship...
Salivary secretion in children after fractionated or single-dose TBIK Garming Legert
Department of Dental Medicine, Division of Oral and Maxillofacial Surgery, Karolinska Institute, Huddinge, Sweden
Bone Marrow Transplant 47:404-10. 2012..49, 95% confidence interval (CI)=1.40-30, P=0.014) and seropositivity of the recipient for 3-4 herpesviruses (OR=6.57, 95% CI=1.26-34, P=0.021) and a low stimulated salivary secretion rate (<0.5 mL/min) was found 1 year after HSCT...
Ex vivo T lymphocyte expansion for retroviral transduction: influence of serum-free media on variations in cell expansion rates and lymphocyte subset distributionS Carlens
Centre for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, and Departments of, Huddinge, Sweden
Exp Hematol 28:1137-46. 2000..While these sera promote cell growth and viability, they contain uncharacterized elements that may yield inconsistent results from batch to batch. Cell expansion in serum-free media would therefore be preferable...
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donorsM Remberger
Department of Clinical Immunology, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 30:761-8. 2002..Overall and relapse-free survival were not improved by the occurrence of acute GVHD...
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in EuropeL Barkholt
Division of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
Ann Oncol 17:1134-40. 2006..CONCLUSION: Patients with metastatic RCC, less than three metastatic locations and a Karnofsky score >70% can be considered for HSCT. Posttransplant DLI and limited chronic GVHD improved the patient survival...
Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unitK Gilli
Department for Anaesthesiology and Intensive Care Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 45:682-8. 2010..01). In multivariate analysis of death, SOFA score was the only significant factor (P<0.001). In conclusion, SOFA score predicted prognosis in ASCT patients treated at the ICU...
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemiaM Uzunel
Department of Clinical Immunology, Karolinska Institute at Huddinge University Hospital, Huddinge, Sweden
Blood 98:1982-4. 2001..005). In conclusion, for patients entering transplantation while they have residual disease, a combination of acute and chronic graft-versus-host disease may be needed to decrease the risk of relapse after SCT...
Increased levels of immune transcript in patients with acute GVHD after allogeneic stem cell transplantationM Jaksch
Division of Clinical Immunology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 31:183-90. 2003..In conclusion, the quantitative RT-PCR of granzyme B, perforin and FasL may serve as a guide to the clinician in diagnosing acute GVHD and monitoring treatment...
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinomaP Hentschke
Center for Allogenic Stem Cell Transplantation and Division of Immunology, Microbiology and Pathology, Huddinge University Hospital, Stockholm, Sweden
Bone Marrow Transplant 31:253-61. 2003..However, the regression of some metastases associated with GVHD provides suggestive evidence that the GVHD effect may occur in renal and colon adenocarcinoma using reduced intensity conditioning...
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donorsPetter Svenberg
Centre for Allogenic Stem Cell Transplantation, Department of Paediatrics, Karolinska University Hospital, Huddinge, SE 14186 Stockholm, Sweden
Biol Blood Marrow Transplant 10:877-82. 2004..We conclude that HSCT with HLA-A, -B, and -DRbeta1 genomically matched unrelated donors in combination with antithymocyte globulin in the conditioning regimen gives encouraging results in patients with SAA or IEM...
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantationMats Remberger
Department of Clinical Immunology, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
Transplantation 78:122-7. 2004..Thymoglobulin given before allo-hematopoietic stem-cell transplantation (HSCT) from unrelated donors reduces acute graft-versus-host disease (GvHD), but the optimal dose is unknown...
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemiaAnna Nordlander
Center for Allogenic Stem Cell Transplantation and Department of Clinical Immunology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Biol Blood Marrow Transplant 10:195-203. 2004..01), and an HLA-matched donor (P=.01). The association between herpes simplex virus infection and a low frequency of relapse is a new observation and may indicate that viral antigens play a role in the induction of an antileukemic effect...
Increased risk of gastrointestinal acute GVHD following the addition of melphalan to busulfan/cyclophosphamide conditioningT Mårtensson
Astrid Lindgren Children s Hospital and Karolinska University Hospital Huddinge, Stockholm, Sweden Department of Clinical Science, Intervention and Technology, CLINTEC, Karolinska Institutet, Stockholm, Sweden
Pediatr Transplant 17:285-93. 2013..5% (five of eight) in the BuCy group. In conclusion, the addition of melphalan to the BuCy conditioning regimen resulted in severe gastrointestinal complications and did not improve overall survival...
Poor oral nutrition after allogeneic stem cell transplantation correlates significantly with severe graft-versus-host diseaseJ Mattsson
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden
Bone Marrow Transplant 38:629-33. 2006..66, confidence interval 1.44-40.7, P=0.016). Poor oral intake early after SCT may be associated with an increased risk of developing severe acute GVHD...
No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cellsM Sundin
Division of Clinical Immunology, Department of Laboratory Medicine, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Cytotherapy 10:238-42. 2008..It has been suggested that MSC may be trapped in bone marrow (BM) filters during the stem cell procurement and lost from the HSC graft...
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decadesBritt Marie Svahn
Center for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Transplantation 81:1600-3. 2006..It was found that the time the patients had GVHD did not differ among the three groups. In conclusion, the costs and survival rates associated with severe acute GVHD has increased in recent years...
Increased immune transcript levels are correlated with acute graft-versus-host disease and cytomegalovirus response after allogeneic stem cell transplantationMarie Jaksch
Division of Clinical Immunology, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden
Transplantation 77:195-200. 2004..Therefore, this study evaluates the gene expression pattern in the peripheral blood of patients after allogeneic stem cell transplantation and correlates the results to acute GVHD...
Cytokine production during myeloablative and reduced intensity therapy before allogeneic stem cell transplantationMats Remberger
Department of Clinical Immunology, Centre of Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital MR, SE 141 86 Stockholm, Sweden
Haematologica 89:710-6. 2004..The aim of this study was to elucidate the effect of the type of chemo-radio therapy given before allogeneic hematopoietic stem-cell transplantation (HSCT) on cytokine release...
Increased gene expression of chemokine receptors is correlated with acute graft-versus-host disease after allogeneic stem cell transplantationMarie Jaksch
Division of Clinical Immunology, Karolinska Institutet at Karolinska University Hospital, Huddinge, Sweden
Biol Blood Marrow Transplant 11:280-7. 2005..Although they are not specific for acute GVHD, quantitative monitoring of the gene expression of chemokine receptors may be a valuable molecular method to monitor and diagnose acute GVHD...
Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantationMats Remberger
Department of Clinical Immunology, Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital, SE 141 86 Stockholm, Sweden
Haematologica 90:931-8. 2005..The role of serum concentrations of rabbit antithymoglobulin (ATG) in the development of acute graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) with unrelated donors is unknown...
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipientsBeatrice Diedrich
Department of Transfusion Medicine, Karolinska University Hospital at Huddinge, Stockholm, Sweden
Transfusion 45:1064-72. 2005..The impact of lowering the platelet (PLT) count threshold for prophylactic PLT transfusion on bleeding and PLT use in allogeneic hematopoietic progenitor cell (HPC) transplant recipients is a matter of debate...
The incidence of hemorrhagic cystitis and BK-viruria in allogeneic hematopoietic stem cell recipients according to intensity of the conditioning regimenGeraldine Giraud
Department of Oncology Pathology, Karolinska Institutet, Stockholm, Sweden
Haematologica 91:401-4. 2006..02). Finally, hemorrhagic cystitis and BK-viruria were less common in patients receiving RIC, rather than full conditioning (p<0.01 and p<0.01, respectively)...
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantationKatarina Le Blanc
Centre for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden
Transplantation 78:1014-20. 2004..6; P=0.03). CONCLUSIONS: NM conditioning with posttransplant immunosuppression using CsA and MMF resulted in less leukopenia and fewer transfusions, but resulted in more cases of graft failure, acute GVHD, and TRM than in RIC patients...
Graft failure in the modern era of allogeneic hematopoietic SCTR Olsson
Center for Allogeneic Stem Cell Transplantation, Karolinska University Hospital, Stockholm, Sweden
Bone Marrow Transplant 48:537-43. 2013..01). In conclusion, graft failure was only associated with inferior survival in malignant disease. Non-malignant disorders, HLA match, conditioning intensity, immunosuppression regimen and cell dose all influenced graft failure risk...
Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institutionH Nahi
Division of Haematology, Department of Medicine, Karolinska Institutet Huddinge and Haematology Centre Karolinska, Karolinska University Hospital Huddinge, 141 86, Stockholm, Sweden
Med Oncol 29:2348-58. 2012..Our study showed that outcome after allo-SCT in de novo AML differs depending on cytogenetic risk-group; however its position in post-remission therapy of eligible AML patients is not threatened...
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantationM Schaffer
Department of Biosciences at Novum, Karolinska Institutet at Huddinge University Hospital, Huddinge, Sweden
Tissue Antigens 62:243-50. 2003..The awareness of HLA class I- and II-mismatches in a recipient-donor pair makes it possible to give appropriate pre- and post-transplantation treatment...
Association between a high BK virus load in urine samples of patients with graft-versus-host disease and development of hemorrhagic cystitis after hematopoietic stem cell transplantationG Bogdanovic
Department of Oncology-Pathology, Karolinska Institute, Hudding University Hospital, Stockholm, Sweden
J Clin Microbiol 42:5394-6. 2004..BKV load in combination with acute GVHD discriminated the best, while BKV and viral load alone, but not GVHD, still showed predictive ability for HC...
Hemorrhagic cystitis: a retrospective single-center surveyZuzana Hassan
Center for Allogenic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
Clin Transplant 21:659-67. 2007..With four risk factors, the risk of HC development was 31%. Risk factors for severe HC of grades 3-5 were aGVHD and bacteremia...
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignanciesKatarina Le Blanc
Division of Clinical Immunology and Transfusion Medicine, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 15:1108-15. 2009..81, P=.02) and aGVHD (HR 0.84, P=.05). These results indicate that LC30 is an independent prognostic factor for transplant outcome in matched unrelated SCT for myelogenous malignancies...
N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitroHelen Karlsson
Division of Clinical Immunology, Karolinska Institutet, Stockholm, Sweden
Eur J Immunol 41:1143-53. 2011..To conclude, NAC appears to increase acute GvHD and has an immunostimulatory effect on alloantigen-specific T cells...
The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantationAnna Nordlander
Department of Clinical Immunology, and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institute, Huddinge University Hospital, Stockholm, Sweden
Br J Haematol 119:1133-6. 2002..01). Acute GVHD grades II-IV were more common among patients homozygous for the IL-10-1064 allele 13 (P = 0.02). Patients homozygous for the TNF-308 allele (AA) correlated with higher TNF-alpha serum levels during conditioning (P = 0.02)...
Granulocyte colony-stimulating factor induced acute and chronic graft-versus-host diseaseOlle Ringden
Division of Clinical Immunology, Centre for Allogeneic Stem Cell Transplantation, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 90:1022-9. 2010..Total body irradiation and bone marrow were found to be prerequisites for acute GVHD. This study encouraged us to perform a retrospective clinical study...
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioningMehmet Uzunel
Department of Clinical Immunology, Karolinska Institute at Karolinska University Hospital, Huddinge, Stockholm, Sweden
Transplantation 82:913-9. 2006..The use of reduced intensity conditioning (RIC) regimens in allogeneic hematopoietic stem cell transplantation (HSCT) has increased over the past five years...
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantationMikael Sundin
Department of Laboratory Medicine, Division of Clinical Immunology F79, Karolinska Institutet, Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden
Haematologica 91:1059-67. 2006..The objective of this study was to determine risk factors in PTLD following HSCT in order to identify high-risk patients for surveillance, prophylaxis and treatment...
Serum levels of cytokines correlate to donor chimerism and acute graft-vs.-host disease after haematopoietic stem cell transplantationMats Remberger
Department of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, Stockholm, Sweden
Eur J Haematol 70:384-91. 2003..Some patients become full donor chimeras (DC) early after stem-cell transplantation (SCT), while others remain mixed chimeras for a longer time. Little is known about the mechanism behind these phenomena...
An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantationMats Remberger
Department of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
Br J Haematol 119:751-9. 2002..These results show that major histocompatibility comlex (MHC) alleles may influence the incidence of GVHD in HSCT with HLA identical sibling donors...
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancerReka Conrad
Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska University Hospital Huddinge, Karolinska Institutet, Stockholm, Sweden
Biol Blood Marrow Transplant 12:346-54. 2006..01). Thus, an increased level of I cytokines possibly mirrors tumor killing induced by type 1 T-cell response. Furthermore, anti-I cytokines might inhibit cytotoxic cells from exerting the antitumor effect of allogeneic SCT...
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centerOlle Ringden
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 81:718-25. 2006..Allogeneic hematopoietic stem cell transplantation (ASCT) is a possible cure for many inherited disorders...
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host diseaseOlle Ringden
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 81:1390-7. 2006..Mesenchymal stem cells (MSC) have immunomodulatory effects. The aim was to study the effect of MSC infusion on graft-versus-host disease (GVHD)...
A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumorsReka Conrad
Karolinska Institutet, Department of Laboratory Medicine, Division of Clinical Immunology, Karolinska University Hospital Huddinge F79, SE 141 86 Stockholm, Sweden
Haematologica 93:265-72. 2008..We performed a non-randomized study comparing low intensity conditioning with reduced intensity conditioning after stem cell transplantation to demonstrate the graft-versus-tumor effect...
Costs of allogeneic hematopoietic stem cell transplantationBritt Marie Svahn
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 82:147-53. 2006..This study aims to determine the total costs after allogeneic hematopoietic stem cell transplantation (ASCT) and factors associated with increases or decreases in costs...
Acute neurological complications after hematopoietic stem cell transplantation in childrenJohanna Rubin
Department of Pediatrics, Karolinska University Hospital, Huddinge, Karolinska Institutet, Stockholm, Sweden
Pediatr Transplant 9:62-7. 2005..Number of positive herpes group viral serologies in the recipient before transplantation and certain electrolyte disturbances may contribute to neurological complications after HSCT...
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II studyKatarina Le Blanc
Haematology Centre and Centre of Allogeneic Stem Cell Transplantation, Division of Clinical Immunology, Karolinska University Hospital, Huddinge, Stockholm, Sweden
Lancet 371:1579-86. 2008..Mesenchymal stem cells modulate immune responses in vitro and in vivo. We aimed to assess whether mesenchymal stem cells could ameliorate GVHD after haemopoietic-stem-cell transplantation...
Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantationUlrica Forslöw
Department of Medicine, Division of Respiratory Medicine and Allergology, Huddinge, Sweden
Scand J Infect Dis 38:970-6. 2006..8% compared to 8.9% during the first decade. We conclude that the rate of mortality related to pneumonia has decreased over time, possibly as a result of improved diagnostic, prophylactic and therapeutic methods and treatment...
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutritionBritt Marie Svahn
Center for Allogeneic Stem Cell Transplantation, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Transplantation 85:1000-7. 2008..Acute graft-versus-host disease (GVHD) was reduced using home care compared with hospital care after allogeneic hematopoietic stem-cell transplantation (ASCT)...
Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in childrenJohan Svennilson
Centre for Allogeneic Stem Cell Transplantation, and Paediatric Haematology Unit, Huddinge University Hospital, Stockholm, Sweden
Pediatr Transplant 7:130-6. 2003..We encourage the use of combination GVHD prophylaxis in children. ABO mismatch should be considered when choosing between otherwise equally suitable donors...
Granulocyte and granulocyte-macrophage colony-stimulating factors in allografts: uses, misuses, misconceptions, and future applicationsOlle T H Ringdén
Center for Allogeneic Stem Cell Transplantation and Division of Clinical Immunology, Karolinska Institutet, Karolinska University Hospital Huddinge, Stockholm, Sweden
Exp Hematol 33:505-12. 2005..G-CSF has no effect on relapse. Available findings suggest that there is no indication to use G-CSF as prophylaxis after ASCT...
